Taiwanese chip maker Himax Technologies Inc. (NASDAQ:HIMX) announced Wednesday that Google Inc. has decided not to exercise its previously issued purchase option to make an additional investment into a Himax unit, Himax Display Inc., which supplies liquid-crystal-on-silicon microdisplay technology for Google Glass. The second round investment decision by Google will not affect the two companies' strategic partnership, according to Himax. Himax Technologies, Inc. (NASDAQ:HIMX) in last trading activity moved down -7.92% to close at $8.02. Company weekly performance is -6.20% while its quarterly performance stands at 38.04%. Himax Technologies, Inc. (NASDAQ:HIMX) is -48.12% away from its 52 week high. BioMarin Pharmaceutical (NASDAQ:BMRN) is scheduled to report third-quarter 2014 results on Oct 23, after the closing bell. Last quarter, the company posted a narrower-than-expected loss due to higher-than-expected revenues. The company has reported a narrower-than-expected loss in three of the last four quarters. Let's see how things are shaping up for this announcement. On last trading day BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) moved up 5.23% to close at $74.71. Its volatility for the week is 3.98% while volatility for the month is 3.26%. BMRN's sales growth for past 5 years was 13.10% and its EPS growth for past 5 years was -44.30%. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) monthly performance is 8.15%. Accuride Corporation (NYSE:ACW), a leading supplier of vehicular spare parts in North America, reported strong financial results last month for the second quarter. Second quarter 2014 net sales from continuing operations were $181.6 million, an 0.9 percent increase year-over-year. The company achieved operating income of $12.3 million for the quarter, compared to $6 million in the second quarter of 2013. Net income from continuing operations was $5.1 million, or $0.11 per share during the quarter, compared to a 2013 second-quarter net loss of $5.1 million, or $0.11 per share. Net income included a benefit of $2.2 million, or $0.04 per share, related to Mexico tax reform and a reduction in long-term income tax payable. Second quarter Adjusted EBITDA improved year-over-year to $23.2 million, or 12.8 percent of net sales, compared to $17.8 million, or 9.9 percent of net sales, in the same quarter of 2013. As of June 30, 2014, Accuride had $31.9 million of cash plus $40.1 million in availability under its ABL Credit Facility, for total liquidity of $72 million. On last trading day Accuride Corp. (NYSE:ACW) moved up 3.26% to close at $4.43. Its volatility for the week is 5.52% while volatility for the month is 5.64%. ACW's sales growth for past 5 years was -7.10% and its EPS growth for past 5 years was 64.10%. Accuride Corp. (NYSE:ACW) monthly performance is -0.45%. HMS Holdings Corp. (NASDAQ:HMSY) today announced it will report third quarter 2014 financial and operating results at 7:30 am CT/8:30 am ET on Tuesday, November 4, 2014. Supplemental financial information, including the press release and presentation, will be released at approximately 5:00 am CT/ 6:00 am ET. HMS Holdings Corp. (NASDAQ:HMSY) has 0.70% insider ownership. In last trading activity company's stock closed at $21.21. Cinedigm Corp (NASDAQ:CIDM) last issued its quarterly earnings data on Wednesday, August 13th. The company reported ($0.15) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.05) by $0.10. The company had revenue of $22.90 million for the quarter, compared to the consensus estimate of $30.16 million. Analysts expect that Cinedigm Corp will post $-0.27 EPS for the current fiscal year. On Tuesday shares of Cinedigm Corp. (NASDAQ:CIDM) closed at $1.63. Company's sales growth for last 5 years was 14.90% and EPS growth for next 5 years is recorded as 10.00%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
